Ono Pharmaceutical Co. Ltd.
OPHLY | OTC
$5.30
+$0.15 (+2.91%)
Sep 22, 2026, 11:42 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | 15.86 | 14.92 | 9.27 | 11.95 | 18.69 | 19.21 |
PEG Ratio | 0.33 | -0.25 | 0.60 | 0.28 | 2.54 | 0.07 |
PS Ratio | 2.16 | 1.53 | 2.36 | 9.04 | 12.49 | 14.05 |
PB Ratio | 1.38 | 0.95 | 1.50 | 5.45 | 6.88 | 6.84 |
P/FCF Ratio | 8.50 | 10.02 | 13.20 | 27.86 | 91.11 | 80.95 |
P/OCF Ratio | 8.13 | 9.05 | 10.72 | 25.33 | 73.02 | 58.74 |
OCF/S Ratio | 26.53 | 16.94 | 22.01 | 35.69 | 17.11 | 23.92 |
Debt / Equity Ratio | 0.14 | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 2.51 | 2.56 | 3.52 | 2.44 | 3.63 | 2.22 |
Current Ratio | 2.86 | 3.07 | 3.99 | 2.81 | 4.27 | 2.64 |
Asset Turnover | 0.49 | 0.46 | 0.55 | 0.51 | 0.49 | 0.41 |
Interest Coverage | 29.20 | 11.23 | 712.24 | 155.49 | 118.07 | 717.74 |
Return on Equity | 8.66% | 6.40% | 16.14% | 15.19% | 12.28% | 11.87% |
Return on Assets | 6.66% | 4.70% | 14.01% | 12.77% | 10.89% | 10.10% |
Return on Invested Capital | 8.39% | 5.32% | 15.70% | 14.66% | 11.73% | 11.23% |
Dividend Yield | 3.38% | 5.03% | 3.14% | 0.74% | 0.61% | 0.52% |
Payout Ratio | 53.80% | 74.96% | 29.05% | 26.39% | 34.36% | 29.76% |
FCF Payout Ratio | 28.69% | 50.38% | 41.39% | 20.50% | 55.83% | 41.82% |
Gross Profit Margin | 72.52% | 69.61% | 74.71% | 75.39% | 74.12% | 72.33% |
Net Profit Margin | 13.53% | 10.28% | 25.46% | 25.21% | 22.28% | 24.39% |
Pretax Profit Margin | 17.96% | 12.19% | 32.57% | 32.10% | 29.06% | 32.62% |
Operating Profit Margin | 20.03% | 12.27% | 32.45% | 31.75% | 28.56% | 31.79% |
FCF Margin | 25.36% | 15.30% | 17.87% | 32.45% | 13.71% | 17.36% |
EBITDA Margin | 27.35% | 18.80% | 35.50% | 36.20% | 34.21% | 37.78% |
Add to Watchlist
Select watchlists to add or remove OPHLY